Stay updated on Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial

Sign up to get notified when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added 2015 ( U.S. NIH Grant/Contract ) to the study identifiers and updated the page revision from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T20:02:28.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page no longer displays the primary condition label 'Multiple myeloma' and omits the related topics and Genetics resource links. This changes how the study content is presented and where users can navigate for additional information.
    Difference
    0.2%
    Check dated 2026-08-15T20:41:25.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page shows a new revision tag, updating from v3.6.4 to v3.6.5. This appears to be a minor site update and does not modify the study content.
    Difference
    0.1%
    Check dated 2026-08-08T18:20:24.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page's related topics now include 'Multiple myeloma' and 'MedlinePlus Genetics', and the page revision tag has been updated from v3.6.3 to v3.6.4.
    Difference
    0.2%
    Check dated 2026-07-25T10:44:17.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The related topics section no longer lists 'Multiple myeloma' and 'MedlinePlus Genetics', removing those links from the page context.
    Difference
    0.2%
    Check dated 2026-07-18T05:35:40.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Related topics on the page were expanded to include 'Multiple myeloma' and a link to 'MedlinePlus Genetics'. This addition enhances navigation by connecting the study page to broader disease and genetics information.
    Difference
    0.2%
    Check dated 2026-07-11T03:29:51.000Z thumbnail image

Stay in the know with updates to Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.